President Donald Trump wasted no time in overturning former President Joe Biden’s Executive Order 14087, a policy that claimed to lower prescription drug costs but instead buried the healthcare system under more bureaucracy. Trump’s swift action on his first day back in the Oval Office signals a return to policies that prioritize market-driven solutions over the left’s heavy-handed government interventions.
Biden’s executive order introduced a patchwork of experimental programs, including capping certain Medicare drug prices at $2 and negotiating pricing for high-cost therapies. It sounded good on paper, but like most Democrat initiatives, it promised much and delivered little. For example, Biden touted this policy as a silver bullet for Americans struggling with high drug costs, but a closer look reveals that it merely created a web of inefficiency, slowing down innovation and driving up costs in the long run.
In Biden’s own words, “Too many Americans face challenges paying for prescription drugs.” Well, no kidding, Joe. After two years of inflationary policies and government overreach, everyday Americans are paying more for everything—including prescription drugs.
In repealing the order, Trump made it clear that Biden’s plans were more about scoring political points than actually helping Americans. “The previous administration embedded deeply unpopular, inflationary, illegal, and radical practices within every agency and office of the federal government,” Trump declared, adding that revoking this order was just the beginning of his efforts to clean house.
Predictably, the Democrats are losing their minds. Alex Floyd, a Democratic National Committee spokesperson, accused Trump of “jacking up the costs of drugs to appease his billionaire backers.” It’s a laughable statement considering it was Biden’s reckless spending that fueled inflation, driving up costs across the board, including healthcare.
By rescinding Biden’s bloated executive order, Trump is paving the way for real solutions. Democrats love to claim they’re sticking it to Big Pharma, but their policies only make it harder for companies to innovate while saddling everyday Americans with higher costs. Trump understands that when you let the free market work, competition drives prices down and improves access for everyone.
For the average American family, this decision is a step toward relief. Biden’s plan might have sounded like a good idea during a campaign speech, but it ignored the bigger picture. Real affordability doesn’t come from government price-fixing—it comes from fostering innovation and competition in a free market. Once again, Trump is showing that his priorities lie with the hardworking Americans who just want to afford their prescriptions without bureaucrats meddling in their wallets.
Comments are closed.